FT : Spain’s Repsol in talks to buy Talisman Energy

Spain’s Repsol in talks to buy Talisman Energy

A Repsol worker walks past the new extension of the Repsol oil refinery in Cartagena, southeastern Spain, April 18, 2012. An incensed Spain threatened swift economic retaliation against Argentina on Tuesday after it seized control of YPF, the South American nation's biggest oil company, in a move which pushed down shares in Spanish energy giant Repsol, the major shareholder. REUTERS/Susana Vera (SPAIN - Tags: ENERGY BUSINESS ROYALS POLITICS)©Reuters
A Repsol refinery in Cartagena
Repsol, the Spanish oil group, is in talks to acquire Talisman Energy of Canada, in a deal that could value the target’s equity at up to $8bn.
Senior Repsol executives are in Calgary for discussions, and hope to have a deal agreed before Christmas, according to one person involved in the negotiations.

The price being negotiated is in a range between $6 and $8 per share, which would represent a premium of up to 117 per cent to Talisman’s share price of C$4.26 on Thursday night. Including debt, the deal would give Talisman an enterprise value of about $10bn to $12bn.
The deal if agreed would be the first large transaction involving energy production companies since the oil price started falling last June.
Talisman confirmed on Monday that it had been “approached by a number of parties, including Repsol, with regards to various transactions”. It added then: “There is no assurance that any transaction will be agreed.”

Talisman was not immediately available for comment on Friday. Repsol declined to comment.
Respsol was first in talks with Talisman about a possible deal over the summer, but decided to pull out because the price for the company would have been too high. Over the past six months, Talisman shares have fallen 62 per cent.
Repsol has about $10bn in cash and short-term instruments available to make acquisitions following the payment of about $5bn in compensation from the government of Argentina over the nationalisation of YPF, the Spanish company’s business in South American country.
Repsol has said it wants to build up its presence in developed countries that are members of the Organisation for Economic Co-operation and Development, rather than exposing itself further to the higher political risks typical of emerging economies.
About half of Talisman’s assets are in North America, including the Eagle Ford and Marcellus shale formations in the US, with another 40 per cent in Asia.

Repsol is keen to acquire more assets in the US and Canada, and is also interested in making its first moves into Asia.
Talisman also own assets in the North Sea that are mature and will incur decommissioning costs at the end of their productive lives, which analysts have suggested are unattractive, particularly in a period of lower oil prices.
However, Repsol is interested in acquiring the expertise in offshore production of Talisman’s workforce.
The Spanish company has had success in offshore exploration, for example on Brazil, but has less of a record in managing production after oil and gasfields have been found.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: SOFO -3.2%, NUS -2.9%, SHW -1.8%, UTX -1.5%, ZQK -1.4%, NDSN -0.6%

Select Chinese related stocks trading lower: JMEI -2.9%, JD -1.2%, ZNH -1.2%, YUM -1.2%.

Select oil/gas related names showing early weakness: LINE -4.4%, PVA -3.7%, MRO -2.6%, RDS.A -1.2%, SLB -0.9%, SDRL -0.8%, OAS -0.8%

Other news: EOX -10.2% (announced appointment of Mike Dickinson to the position of COO; reduced Q4 average production guidance to 3,300 BOEPD; lowered FY15 production and CapEx guidance), SNTA -4.6% (announces preliminary results from an investigator-sponsored phase 1 trial; plans to further evaluate ganetespib in combination with trastuzumab and pertuzumab for HER2+ MBC), VOD -2% (still checking), WIN -1.9% (announced that Bob Gunderman has been named chief financial officer for the company, effective immediately; also unfavorable commentary on Thursday's Mad Money), AKR -1.8% (announces sale of 3.4 million common shares), PVG -1.8% (announced a non-brokered private placement of ~12.8 mln shares), CPLP -1.7% (announed that it has secured time charter employment for the M/T 'Aias' and M/T 'Arionas'), ALU -1.7% (still checking), SKYW -1.3% (reported combined November 2014 traffic For SkyWest Airlines and ExpressJet Airlines; 3.7% decrease in revenue passenger miles, available seat miles decreased 4.0%), ARMK -1.3% (prices 30 mln shares of common stock sold by certain stockholders at $28.00 per share), ACT -1.2% (confirms District Court ruling to require continued distribution of NAMENDA IR), TSLA -0.9% (China exec may leave the company, according to reports)

Analyst comments: GDP -7.7% (downgraded to Underweight from Overweight at JP Morgan), BBEP -3.1% (downgraded to Hold from Buy at Wunderlich), VMW -2.1% (resumed with a Underweight from Overweight at Piper Jaffray; tgt lowered to $69 from $111), ZAYO -1.9% (downgraded to Neutral from Buy at BTIG Research), HOV -1.9% (downgraded to at ), MR -1.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley), MS -1.1% (also announced a restructuring program across its entire 11-park enterprise), COST -1.1% (downgraded to Neutral from Buy at Janney)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: ADBE +5.9%, EMKR +5.7%, ( names Jeffrey Rittichier CEO), HGSH +1.3%

M&A news: TLM +10.6% (attributed to reports suggesting Repsol (REPYY) bid )

Select airline names showing strength: UAL +1.6%, AAL +1.2%, GOL +0.9%, LUV +0.8%

Other news: CCXI +115.1% (announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy with CCX140), WTSL +80.1% (still checking; light volume), FRO +30.7% (cont strength), ONTY +14% (positive ONT-380 Data; Phase 1 data demonstrate preliminary clinical activity; also announced that Array BioPharma (ARRY) has granted Oncothyreon an exclusive license to develop, manufacture and commercialize ONT-380), TLM +10.6% (attributed to reports suggesting Repsol (REPYY) bid ), NBG +5.6% (modest rebound following weakness this week), AHC +4.9% (announced special cash dividend of $2.25 per share), DENN +3.8% (favorable commentary on Thursday's Mad Money), FCEL +3.1% (announces final acceptance of largest fuel cell power plant made and operating in Germany), SSRI +2% (expands mineral resources at marigold with higher gold grade mineralization), NCLH +1.8% (following late move lower on cruiseship fire news), SEAS +1.3% (announced that David D'Allesandro was named interim CEO; also announced a restructuring program across its entire 11-park enterprise), PPHM +1.3% (announces preclinical data from recently conducted single agent studies; statistically significant tumor growth suppression with single agent Bavituximab equivalent), FTR +1.2% (co's Board approved a 5% increase in the quarterly dividend to $0.105 from $0.10 per share), FCE.A +1.1% (Signature Global Asset Management discloses 5.16% passive stake in 13G filing)

Analyst comments: GPRO +4.3% (upgraded to Overweight from Neutral at JP Morgan), DAL +1.4% (target raised to $60 from $48, maintain Buy at Deutsche Bank
)

>>> US Early premarket gappers

Early premarket gappers
Gapping up: CCXI +63.9%, FRO +21.5%, TLM +11.7%, NBG +8.3%, ADBE +7.5%, EMKR +5.7%, EOX +5.5%, GPRO +3.2%, AHC +2.5%, FCEL +2.5%, CLF +2.3%, NCLH +1.8%, PLUG +1.6%, SEAS +1.3%, HGSH +1.3%, FTR +1.2%, FCE.A +1.1%, X +1.1%

Gapping down: RSH -22.5%, SOFO -3.2%, GDP -3.1%, JMEI -2.9%, SHW -2.8%, AU -2.1%, VOD -1.9%, PVG -1.8%, OAS -1.8%, CPLP -1.7%, ARMK -1.7%, MS -1.5%, UTX -1.5%, AKR -1.4%, JD -1.4%, ZQK -1.4%, SKYW -1.3%, RCL -1.3%, SPLS -1.2%, ALU -1.2%, SLB -1.2%, ZNH -1.2%, TWTR -1.1%, C -1.1%, RDS.A -1%, TSLA -0.9%

>>> BBRY - Oppenheimer maintains Perform rating citing belief FY16 will be anoth

Oppenheimer maintains Perform rating citing belief FY16 will be another transition year 
- Firm believes BBRY has put in place the best strategy to return the company to growth, and several recent initiatives/partnerships will contribute to this. However, they see it taking time and ultimately believe FY16 (ending Feb. '16) will be another transition year primarily due to weak hardware device sales.
- Firm lowers their FY15 and FY16 revenues/EPS from 4.26B/-$0.09 and $5.20B/$0.42 to $3.61B/-$0.22 and $3.16B/-$0.49 respectively, based on lower device sale assumptions and service revenues contribution.